|
WO2020141157A1
|
|
Methods and biomarkers for predicting efficacy and evaluation of treatment with drugs modulating neprilysin activity.
|
|
CN103703373A
|
|
Method for determining the risk of cardiovascular events using igfbp fragments
|
|
KR20120102499A
|
|
Detection of igfbp-4 fragments as a diagnostic method
|
|
US2009163415A1
|
|
NT-proBNP, proBNP AND BNP IMMUNOASSAYS, ANTIBODIES AND STABLE STANDARD
|
|
WO2009066010A1
|
|
Method for detecting nt-probnp or the nt-probnp/probnp ratio
|
|
CA2683911A1
|
|
Immunoassay for quantification of an unstable antigen selected from bnp and probnp
|
|
CN101641601A
|
|
Stable standards for BNP immunoassays
|
|
EP2021369A2
|
|
Antibodies and standard for nt-probnp and probnp immunoassays
|
|
US7285418B2
|
|
Method and kit for the diagnosis of troponin I
|
